Variant report
Variant | esv3343265 |
---|---|
Chromosome Location | chr13:85203772-85204044 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528095622 | chr13:85203817-85203818 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9575620 | chr13:85203864-85203865 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs561338058 | chr13:85203889-85203890 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191616947 | chr13:85203902-85203903 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1446789 | chr13:85203913-85203914 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs563753978 | chr13:85203928-85203929 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541783475 | chr13:85203945-85203946 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182906133 | chr13:85203946-85203947 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150112766 | chr13:85203994-85203995 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372358971 | chr13:85203995-85203996 | Weak transcription Active TSS Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374419154 | chr13:85204008-85204009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369210330 | chr13:85204009-85204010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370161794 | chr13:85204010-85204011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374515638 | chr13:85204011-85204012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552283621 | chr13:85204026-85204027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1446788 | chr13:85204036-85204037 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs528387148 | chr13:85204040-85204041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 20502679 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85200200-85211400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr13:85203200-85204000 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr13:85203400-85203800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr13:85203400-85203800 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr13:85203400-85203800 | Flanking Bivalent TSS/Enh | NHEK | skin |
6 | chr13:85203600-85203800 | Bivalent Enhancer | HMEC | breast |
7 | chr13:85203800-85204000 | Bivalent Enhancer | NHEK | skin |